A prospective, multi-center, single-arm study of tOCP/Col for guided bone regeneratio
- Conditions
- bone defect
- Registration Number
- JPRN-UMIN000018192
- Lead Sponsor
- TOYOBO CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
Patient suffering severe hepatopathy, renal disorders, and heart disease who would affect safety evaluation of this trial. Patient who has an allergy drug. Patient who has a bone metabolism disease like osteoporosis or has a medication of bisphosphonate. Patient who has a medication of steroid or immunosuppressant (The local administration is excluded). Patient who receives an anticoagulant therapy. Patient who is pregnant, possibly pregnant, nursing or considering pregnancy. Patient who has an uncontroled diabetes. Smoker, but the patient who was able to confirm intention of the smoking cessation before clinical trial participation is excluded. Patient who participated other clinical trial program within 3 months prior to the study entry Others, patient who is unfit for the study as determined by the principal investigator or sub-investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method